Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Huanglong Granules
- Development stage
- Unknown
- Lead developer
- Chongqing Hilan Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xiao'er Huanglong Granules is a Traditional Chinese Medicine (TCM) formulation developed by Chongqing Xieran Pharmaceutical Co., Ltd. for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children. It was approved by the China National Medical Products Administration (NMPA) in 2013 as a Class 6.1 new TCM drug. The formula is designed to address the TCM patterns of kidney deficiency and liver hyperactivity, as well as phlegm-fire disturbing the heart. It aims to improve attention, reduce hyperactivity and impulsivity, and stabilize mood by modulating the balance of neurotransmitters in the central nervous system. Clinical trials have demonstrated its efficacy and safety in pediatric populations, positioning it as a common alternative or adjunct to stimulant medications in China.
- Brand names
- Xiao'er Huanglong GranulesXiaoer Huanglong Keli
- Other names
- Xiaoer Huanglong KeliHuanglong Granules
02
Targets
NET (Norepinephrine Transporter)DAT (Dopamine plasma membrane transport protein)
Beyond the preview
Go deeper on Xiao'er Huanglong Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiao'er Huanglong Granules.